Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® Biotech Investing
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test Medical Device Investing
Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study Biotech Investing
Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Cannabis Investing News
Health Canada Approves VENCLEXTA® in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia Biotech Investing
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Biotech Investing
Abbott Develops New Pedialyte® Hydration Solution to Help Support Immune Health Medical Device Investing
Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors Cannabis Investing News
BELLUS Health Announces First Patient Dosed in its Phase 2 BLUEPRINT Trial of BLU-5937 for the Treatment of Chronic Pruritus Associated with Atopic Dermatitis Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness
